Scientific publications

Scientific Reports, 2022

Plasma proteomic characterization of the development of acute kidney injury in early sepsis patients

Star B., Boahen C., van der Slikke E. et al.

Archives of Microbiology & Immunology, 2022

Circulating Cell-Free DNA and Systemic Inflammatory Response after Self-Expandable Metal Stent for Malignant Bowel Obstruction

Broholm M, Bojesen R, Gögenur M et al.

Diagnostics, 2022

Proteomic Analysis of Pleural Effusions from COVID-19 Deceased Patients: Enhanced Inflammatory Markers

Razaghi A., Szakos A., Alouda M. et al.

Clinical Proteomics, 2022

Determination of temporal reproducibility and variability of cancer biomarkers in serum and EDTA plasma samples using a proximity extension assay

Christensen T., Maag E., Madsen K. et al.

Nature Aging, 2022

CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels

del Campo M., Peeters C., Johnson E. et al.

European Heart Journal Open, 2022

NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients

Rossignol P., Duarte K., Bresso E. et al.

Human Molecular Genetics, 2022

Identifying causal serum protein–cardiometabolic trait relationships using whole genome sequencing

Png G., Gerlini R., Hatzikotoulas K. et al.

BMJ Open Diabetes Research & Care, 2022

Pregnancy induces pancreatic insulin secretion in women with long-standing type 1 diabetes

Espes D., Magnusson L., Caballero-Corbalan J. et al.

Obesity, 2022

The inflammatory proteome, obesity, and medical weight loss and regain in humans

Perry A., Tanriverdi K., Risitano A. et al.

Clinical and Translational Science, 2022

ST2 and CSF‐1 as potential druggable targets of inflammatory bowel diseases: Results from two‐sample Mendelian randomization study

Mi J., Wu X., Bai X. et al.

Journal of Clinical Immunology, 2022

Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 Patients

Ebihara T., Matsubara T., Togami Y. et al.

PLOS ONE, 2022

Protein biomarker profiles in serum and CSF in 158 patients with PTLDS or persistent symptoms after presumed tick-bite exposure compared to those in patients with confirmed acute neuroborreliosis

Nilsson K., Skoog E., Edvinsson M. et al.

Obesity, 2022

Proteomics, dietary intake, and changes in cardiometabolic health within a behavioral weight‐loss intervention: A pilot study

Hill E., Siebert J., Yazza D. et al.

Journal for ImmunoTherapy of Cancer, 2022

Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors

Natoli M., Hatje K., Gulati P. et al.

Cell Systems, 2022

Pre-infection antiviral innate immunity contributes to sex differences in SARS-CoV-2 infection

Sauerwald N., Zhang Z., Ramos I. et al.

Scientific Reports, 2022

Discovery of four plasmatic biomarkers potentially predicting cardiovascular outcome in peripheral artery disease

Kremers B., Posma J., Heitmeier S. et al.

Journal for ImmunoTherapy of Cancer, 2022

First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors

Davis E., Martin-Liberal J., Kristeleit R. et al.

Allergy, 2022

Development of sensitization to peanut and storage proteins and relation to markers of airway and systemic inflammation: A 24‐year follow‐up

Tedner S., Klevebro S., Bergström A. et al.

Biomedicines, 2022

Quantitative Proteomics Indicate Radical Removal of Non-Small Cell Lung Cancer and Predict Outcome

Bodén E., Andreasson J., Hirdman G. et al.

Journal of Proteome Research, 2022

Plasma Olink Proteomics Identifies CCL20 as a Novel Predictive and Diagnostic Inflammatory Marker for Preeclampsia

Wang X., Yip K., He A. et al.